- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Induction Durvalumab
Total 10443 results
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingHepatocellular CarcinomaChina
-
Oslo University HospitalAstraZenecaActive, not recruitingCancer | NSCLC | Non Small Cell Lung Cancer | NSCLC, Stage III | Non Small Cell Lung Cancer Stage IIINorway, Finland, Lithuania, Estonia
-
Institut für Klinische Krebsforschung IKF GmbH...AstraZeneca; Thoraxklinik-Heidelberg gGmbHRecruiting
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Universidad Nacional de CórdobaRecruiting
-
AstraZenecaKappa SantéRecruiting
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Ospedale Policlinico San MartinoBayer; Associazione Italiana per la Ricerca sul Cancro; Gruppo Italiano per lo...RecruitingColorectal Cancer Stage IV | No Evidence of Disease StateItaly
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Yonsei UniversityCompleted
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
Hark Kyun KimRecruiting
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
AstraZenecaCompleted
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
Qilu Hospital of Shandong UniversityUnknownCatheterization, Peripheral | Catheterization, Central VenousChina
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
ETOP IBCSG Partners FoundationAstraZeneca AG SwitzerlandNot yet recruiting
-
AstraZenecaActive, not recruiting
-
Institut Claudius RegaudActive, not recruiting
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
University Medical Center GroningenCambridge University Hospitals NHS Foundation TrustRecruitingEsophageal CancerNetherlands
-
Asan Medical CenterSamsung Medical CenterActive, not recruitingCholangiocarcinoma | Biliary Tract Neoplasms | Gallbladder CancerKorea, Republic of
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingUrothelial CancerGermany, Switzerland
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Shanghai First Maternity and Infant HospitalUnknown
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
Institut Cancerologie de l'OuestAstraZenecaActive, not recruitingBone Metastases | Prostate Cancer Patients | Node; ProstateFrance
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
MedPacto, Inc.AstraZenecaNot yet recruitingUrothelial Carcinoma Recurrent | Advanced Urothelial CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Australia
-
Monika Joshi, MDAstraZenecaActive, not recruiting
-
Seoul National University HospitalUnknownDurvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLCKorea, Republic of
-
AstraZenecaCompletedSmall Cell Lung Carcinoma Extensive DiseaseChina
-
RenJi HospitalRecruitingLiver Transplant; Complications | Liver CarcinomaChina
-
University of CologneAstraZenecaRecruiting
-
Swiss Group for Clinical Cancer ResearchCompletedNSCLC Non-small Cell Lung CancerSwitzerland
-
Wuhan Union Hospital, ChinaUnknownSmall Cell Lung Cancer | Anlotinib | Durvalumab
-
National University Hospital, SingaporeUnknownOvarian Clear Cell CarcinomaSingapore
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Seoul National University... and other collaboratorsNot yet recruiting
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of